Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phytopharmaceuticals for hospitalized adults with COVID-19 in Togo
PACTR202009483194545Phase 2Recruiting
- Sponsor
- University of Lomé
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of Immunitum, hydroxychloroquine and azithromycin in coronavirus disease 2019 (COVID-19) (5 arms), sponsored by University of Lomé. Primary endpoint: Proportion of patients with undetectable viral load. Started Oct 2020; status: recruiting.
02
Drugs
Immunitumhydroxychloroquineazithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202009483194545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202009483194545.